Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results

Saad Z. Usmani, María‐Victoria Mateos, Vânia Hungria, Shinsuke Iida, Nizar J. Bahlis, Hareth Nahi, Hila Magen, Michèle Cavo, Cyrille Hulin, Darrell White, Valerio De Stefano, John Fastenau, Mary Slavcev, Christoph Heuck, Xiang Qin, Huiling Pei, Tara Masterson, Kristen Lantz, Katharine S. Gries